Showing 2,793 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP policies & guidelines

Councils seek NHS funding to cover drug trial pressures

Editor's pick
Health Service Journal
27 March 2019
PrEP science

An Australian Doctor Has Some Answers About PrEP User With HIV

Editor's pick
HIV Plus
26 March 2019
PrEP policies & guidelines

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

Editor's pick
The Body
24 March 2019
People & personal stories

‘I am prepared’: Steve Spencer on becoming HIV positive in the era of PrEP and U=U

Editor's pick
Star Observer
22 March 2019
PrEP science

'In complete shock': Sydney man contracts HIV despite taking PrEP drug

Editor's pick
Sydney Morning Herald
22 March 2019
PrEP policies & guidelines

Rapidly Starting PrEP Before All Labs Are Back Proves Feasible in NYC

Editor's pick
Poz
21 March 2019
PrEP programmes & uptake

Getting on PrEP is harder than you think

Editor's pick
Whyy
21 March 2019
PrEP programmes & uptake

PrEP Use Among Gay and Bi Men Hits a New High

Editor's pick
Poz
21 March 2019
PrEP science

On-Demand PrEP With TDF/FTC Not Associated With Clinically Relevant Decline in Kidney Function

Editor's pick
Contagion Live
20 March 2019
PrEP

Urine test can provide accurate point-of-care results about PrEP adherence

News
19 March 2019
HIV prevention policy

LGBT+ health adviser urges Britain to make HIV-prevention drug free

Editor's pick
Reuters
18 March 2019
People & personal stories

Obituary: Mags Portman died on February 6th

Editor's pick
The Economist (requires free registration)
15 March 2019
PrEP science

Jean-Michel Molina, MD, on Biomedical Failures of PrEP: Rare, But Serious

Editor's pick
Contagion Live
14 March 2019
Government, leadership & policy

Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Editor's pick
The New York Times
14 March 2019
PrEP policies & guidelines

Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Editor's pick
FiercePharma
14 March 2019
PrEP science

TAF: Quick-dissolve combination PrEP insert is effective against HIV infections in monkeys; intermittent solo pill less so

News
13 March 2019
PrEP programmes & uptake

Young Black Men at Risk for HIV Underestimate Threat

Editor's pick
Medscape (requires free registration)
12 March 2019
PrEP policies & guidelines

Sadiq Khan: Cash row is denying Londoners access to HIV ‘wonder drug’

Editor's pick
Evening Standard
12 March 2019
PrEP policies & guidelines

How Many More Must Needlessly Contract HIV Before We Ensure Proper Access To PrEP?

Editor's pick
Huffington Post
12 March 2019
PrEP science

Effective HIV Interventions Have Changed the Approach to Trials

Editor's pick
Infectious Diseases Consultant
11 March 2019
PrEP programmes & uptake

People stay on PrEP for 14 months on average in the US, study finds

News
10 March 2019
PrEP programmes & uptake

PrEP use jumps to 35 percent among gay and bi men at risk of HIV

Editor's pick
NBCNews.com
8 March 2019
PrEP science

How many people who have used PrEP get HIV the same year? New York study finds out

News
7 March 2019
PrEP science

Descovy is non-inferior to Truvada for daily PrEP

News
6 March 2019